| Name | Title | Contact Details |
|---|
Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical needs in oncology and rare diseases.
Pediapharm Inc. is a Verdun, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Stone and Magnanini is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Investor Relations website contains information about Cingulate Incs business for stockholders, potential investors, and financial analysts.